 |
Our
mission |
|
|
| |
Zephyr ProteomiX platform technologies provides solutions for microarray-based multiplex measurements, HTS and a variety of affinity and recombinant approaches, based on Zephyrin’s proprietary technology. Our mission is to become a worldwide provider of protein, peptide and small molecule microarray technologies, microarray-based HTS solutions and a major supplier of custom affinity-based products. It is our ambition to provide our customers comprehensive and high quality services and products in short turn-around time with cost-effective prices.
Our business strategy
Zephyr’s business strategy has various independent tracks. The company offers its proprietary products and services on the basis of fee-for-service and risk-sharing collaborations. In addition, the company strives to integrate its proprietary microarray expertise into the technology and product lines of selected partners. In parallel, Zephyr has established an independent pipeline of products for the microarray and proteomics fields. Zephyr has a strong record of achievement and is active in the following fields:
- Production of peptide and antibody microarrays for lead discovery and diagnostic purposes.
- Small-molecule microarray for interaction studies.
- Mapping of linear and conformational antibody epitopes.
- Substrate profiling microarray for proteases and kinases and carbohydrate hydrolases.
- Developing high-throughput screening (HTS)-based microarray assays.
- Expression and production of high-quality recombinant peptides and proteins.
- Developing and manufacturing cost-effective affinity-based products.
 | |
|
|
